Stock 600252 GUANGXI WUZHOU ZHONGHENG GROUP CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

All News Guangxi Wuzhou Zhongheng Group Co.,Ltd

Equities

600252

CNE0000015F9

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 28/05/2024 am IST 		5-day change 1st Jan Change
2.36 CNY -2.07% Intraday chart for Guangxi Wuzhou Zhongheng Group Co.,Ltd -2.88% -5.98%
29/04 Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
17/04 Guangxi Wuzhou Zhongheng Group Co.,Ltd commences an Equity Buyback for CNY 200 million worth of its shares, under the authorization approved on March 28, 2024. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd commences an Equity Buyback for CNY 200 million worth of its shares, under the authorization approved on March 28, 2024.
CI
Guangxi Honggui Capital Operation Group Co.,Ltd. agreed to acquire 18% stake in Guangxi United Asset Management Co., Ltd from Guangxi Wuzhou Zhongheng Group Co.,Ltd for approximately CNY 190 million.
CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Lummy Pharma Gets Nod to Raise Dosage of Gastric Drug
MT
Wuzhou Zhongheng’s Drug For Preventing Chemotherapy-Related Nausea Passes Consistency Test
MT
Sealand Securities Co., Ltd. announced that it has received CNY 3.192189985 billion in funding from a group of investors
CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to S&P Global BMI Index
CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) added to FTSE All-World Index
CI
Wuzhou Zhongheng Gets Nod to Trial Ovarian Cancer Drug
MT
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Guangxi Wuzhou Zhongheng Receives 42 Million Yuan in Government Subsidy
MT
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Restrictions on Guangxi Wuzhou Zhongheng Drugs in 2022 Chinese Drug Catalogue Amended
MT
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from S&P Global BMI Index
CI
Guangxi Wuzhou Zhongheng Group Co.,Ltd(XSSC:600252) dropped from FTSE All-World Index
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600252 Stock
  4. News Guangxi Wuzhou Zhongheng Group Co.,Ltd